An Eight-week, Randomized, Double-blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 mg Per Day in Patients Hospitalized for Severe Depression.
Latest Information Update: 05 Sep 2014
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 05 Sep 2014 New trial record